Cheng‐Xin Gong
- Physiology top 0.05%
- Molecular Biology top 0.5%
- Cellular and Molecular Neuroscience top 0.5%
- Neurology top 0.1%
- Pharmacology top 0.2%
- Topics
- Alzheimer's disease research and treatments (111 papers)Neuroscience and Neuropharmacology Research (25 papers)Glycosylation and Glycoproteins Research (23 papers)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Cheng‐Xin Gong
169 papers receiving 15.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Physiology 9.5k
- Molecular Biology 7.5k
- Cellular and Molecular Neuroscience 3.3k
- Neurology 2.5k
- Pharmacology 2.4k
Countries citing papers authored by Cheng‐Xin Gong
This map shows the geographic impact of Cheng‐Xin Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Xin Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Xin Gong more than expected).
Fields of papers citing papers by Cheng‐Xin Gong
This network shows the impact of papers produced by Cheng‐Xin Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Xin Gong. The network helps show where Cheng‐Xin Gong may publish in the future.
Co-authorship network of co-authors of Cheng‐Xin Gong
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Xin Gong. A scholar is included among the top collaborators of Cheng‐Xin Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Xin Gong. Cheng‐Xin Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 60 | |
| 4 | 44 | |
| 5 | 20 | |
| 6 | 21 | |
| 7 | 34 | |
| 8 | 64 | |
| 9 | 55 | |
| 10 | 79 | |
| 11 | 17 | |
| 12 | 47 | |
| 13 | 160 | |
| 14 | 340 | |
| 15 | 302 | |
| 16 | 161 | |
| 17 | 59 | |
| 18 | 49 | |
| 19 | 67 | |
| 20 | 114 |
About Cheng‐Xin Gong
Cheng‐Xin Gong is a scholar working on Physiology, Developmental Neuroscience and Neurology, having authored 170 papers that have together received 16.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (111 papers), Neuroscience and Neuropharmacology Research (25 papers) and Glycosylation and Glycoproteins Research (23 papers). The work is most often cited by research in Physiology (9.5k citations), Neurology (2.5k citations) and Biological Psychiatry (678 citations). Cheng‐Xin Gong has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Khalid Iqbal, Inge Grundke‐Iqbal, Fei Liu, F. Liu, Ying Liu, Chun‐Ling Dai, Jerzy Węgiel, Jianhua Shi, Zhihou Liang and Alejandra del C. Alonso. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.